Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
1 clinical trials · Condition
◉ Watch Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
| Record | Firm | Date |
|---|---|---|
| A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations (NCT05788536) | Regeneron Pharmaceuticals | 2023-06-27 |
Track Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF) automatically
Every clearance here is in the API, with alerts when new ones post.